Akebia Therapeutics, Inc. (AKBA)
0.9001
-0.01
(-0.72%)
USD |
NASDAQ |
Aug 24, 16:00
0.9001
0.00 (0.00%)
After-Hours: 20:00
Akebia Therapeutics Market Cap : 244.60M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 246.36M |
| August 20, 2026 | 249.84M |
| August 19, 2026 | 240.60M |
| August 18, 2026 | 231.47M |
| August 17, 2026 | 233.70M |
| August 14, 2026 | 237.18M |
| August 13, 2026 | 236.31M |
| August 12, 2026 | 242.72M |
| August 11, 2026 | 235.46M |
| August 10, 2026 | 229.35M |
| August 07, 2026 | 247.26M |
| August 06, 2026 | 259.35M |
| August 05, 2026 | 350.55M |
| August 04, 2026 | 358.70M |
| August 03, 2026 | 355.98M |
| July 31, 2026 | 353.63M |
| July 30, 2026 | 361.66M |
| July 29, 2026 | 337.55M |
| July 28, 2026 | 340.23M |
| July 27, 2026 | 342.91M |
| July 24, 2026 | 326.84M |
| July 23, 2026 | 326.84M |
| July 22, 2026 | 337.55M |
| July 21, 2026 | 348.27M |
| July 20, 2026 | 342.91M |
| Date | Value |
|---|---|
| July 17, 2026 | 358.98M |
| July 16, 2026 | 375.06M |
| July 15, 2026 | 369.70M |
| July 14, 2026 | 375.06M |
| July 13, 2026 | 369.70M |
| July 10, 2026 | 375.06M |
| July 09, 2026 | 383.09M |
| July 08, 2026 | 380.42M |
| July 07, 2026 | 364.34M |
| July 06, 2026 | 348.27M |
| July 02, 2026 | 332.19M |
| July 01, 2026 | 324.16M |
| June 30, 2026 | 305.40M |
| June 29, 2026 | 297.37M |
| June 26, 2026 | 305.40M |
| June 25, 2026 | 278.61M |
| June 24, 2026 | 283.97M |
| June 23, 2026 | 294.69M |
| June 22, 2026 | 292.01M |
| June 18, 2026 | 286.65M |
| June 17, 2026 | 273.26M |
| June 16, 2026 | 263.61M |
| June 15, 2026 | 251.48M |
| June 12, 2026 | 247.67M |
| June 11, 2026 | 240.95M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Emergent BioSolutions, Inc. | 265.22M |
| Exelixis, Inc. | 13.58B |
| ADMA Biologics, Inc. | 2.151B |
| Arcutis Biotherapeutics, Inc. | 3.113B |
| Relay Therapeutics, Inc. | 4.318B |
Market Cap Related Metrics
| PS Ratio | 1.106 |
| Price to Book Value | 9.776 |
| Price to Free Cash Flow | 6.016 |
| Price | 0.9001 |
| Earnings Yield | -12.33% |